TWST - Twist Bioscience Corp
IEX Last Trade
43.25
-1.650 -3.815%
Share volume: 1,057,596
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$44.90
-1.65
-3.68%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2022-11-28 | 2023-02-07 | 2023-05-08 | 2023-08-07 | 2023-11-21 | 2024-02-02 | 2024-05-02 | 2024-08-02 | |
| Assets | |||||||||
| Total Assets | 961.378 M | 909.970 M | 853.924 M | 810.332 M | 776.403 M | 732.815 M | 702.846 M | 638.118 M | |
| Current Assets | 596.483 M | 541.859 M | 489.271 M | 445.537 M | 424.256 M | 390.231 M | 371.869 M | 361.831 M | |
| Inventories | 39.307 M | 44.597 M | 39.923 M | 36.354 M | 32.063 M | 30.863 M | 30.376 M | 28.484 M | |
| Other Current Assets | 11.914 M | 14.115 M | 13.503 M | 9.458 M | 11.716 M | 12.870 M | 12.158 M | 11.941 M | |
| Short Term Investments | 11.914 M | 14.115 M | 13.503 M | 9.458 M | 11.716 M | 12.870 M | 12.158 M | 11.941 M | |
| Total Receivables | 40.294 M | 44.437 M | 48.187 M | 42.580 M | 44.064 M | 35.354 M | 35.993 M | 31.988 M | |
| Current Cash | 504.968 M | 438.710 M | 387.658 M | 357.145 M | 336.413 M | 311.144 M | 293.342 M | 289.418 M | |
| Total Non-current Assets | 364.895 M | 368.111 M | 364.653 M | 364.795 M | 352.147 M | 342.584 M | 330.977 M | 276.287 M | |
| Property Plant Equipment | 139.441 M | 144.850 M | 146.539 M | 140.778 M | 131.830 M | 126.225 M | 121.339 M | 106.339 M | |
| Other Assets | 3.385 M | 2.922 M | 2.201 M | 6.024 M | 5.681 M | 5.418 M | 5.395 M | 5.224 M | |
| Intangible Assets | 59.738 M | 58.361 M | 57.068 M | 55.775 M | 54.483 M | 53.190 M | 51.898 M | 14.741 M | |
| Goodwill | 85.811 M | 85.811 M | 85.811 M | 85.811 M | 85.811 M | 85.811 M | 85.811 M | 85.811 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 961.378 M | 909.970 M | 853.924 M | 810.332 M | 776.403 M | 732.815 M | 702.846 M | 638.118 M | |
| Total liabilities | 171.993 M | 163.645 M | 149.992 M | 152.782 M | 152.971 M | 142.773 M | 142.715 M | 146.979 M | |
| Total current liabilities | 90.663 M | 83.837 M | 72.108 M | 72.822 M | 73.323 M | 65.228 M | 67.490 M | 73.757 M | |
| Accounts Payable | 20.092 M | 20.113 M | 13.236 M | 12.184 M | 14.052 M | 9.256 M | 7.703 M | 6.626 M | |
| Other liabilities | 60.000 K | 60.000 K | 60.000 K | 60.000 K | 475.000 K | 475.000 K | 421.000 K | 597.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 60.000 K | 60.000 K | 60.000 K | 60.000 K | 475.000 K | 475.000 K | 421.000 K | 597.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 789.385 M | 746.325 M | 703.932 M | 657.550 M | 623.432 M | 590.042 M | 560.131 M | 491.139 M | |
| Common stock | 55.869 M | 56.444 M | 56.777 M | 57.041 M | 57.278 M | 57.497 M | 57.779 M | 58.145 M | |
| Retained earnings | -828.416 M | -870.240 M | -929.396 M | -986.791 M | -1.033 B | -1.076 B | -1.122 B | -1.207 B |